Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial

DOI Full Paper Access

173

Citations

28

References

2020

Year

Jieqiong Liu, Qiang Liu, Ying Li, Qian Li, Fengxi Su, Herui Yao, Shicheng Su, Quanren Wang, Liang Jin, Ying Wang,

Journal for ImmunoTherapy of Cancer

Abstract

NCT03394287.

References

	Year	Citations

Page 1